Kewaunee Scientific VP sells $99,000 in company stock

Published 01/06/2025, 01:18 PM
KEQU
-

In a recent transaction, Noble Ryan S., Vice President of Sales & Marketing for the Americas at Kewaunee Scientific Corp (NASDAQ:KEQU), sold 1,500 shares of the company's common stock. The shares were sold at a price of $66 each, amounting to a total sale value of $99,000. Following this transaction, Noble retains ownership of 11,823 shares in the company. This move comes as part of routine financial management and reflects ongoing activities within the company. According to InvestingPro analysis, the stock currently appears overvalued, with technical indicators suggesting overbought conditions. Subscribers can access 12 additional ProTips and comprehensive insider trading analysis to make more informed investment decisions.

In other recent news, Kewaunee Scientific Corporation has made strategic advancements with the acquisition of Nu Aire, a Minneapolis-based company, for $55 million. This move is expected to enhance Kewaunee's market presence and expand its product offerings. Nu Aire, a company with a 50-plus-year history, is known for its specialization in biological safety cabinets, airflow products, and various laboratory and pharmacy equipment.

The acquisition is seen as a pivotal step for Kewaunee, particularly in regions where it previously had no distribution partners. This combined organization aims to address the evolving needs of laboratory environments and capitalize on the ongoing investments in life sciences, healthcare, and education sectors globally.

In other recent developments, Kewaunee Scientific Corporation disclosed the outcomes of its Annual Meeting of Shareholders. Key decisions included the re-election of Mr. Keith M. Gehl as a Class II director and the ratification of the appointment of Forvis Mazars, LLP as the company’s independent auditors for the fiscal year 2025. These recent developments reflect the continuous progress and strategic decisions within Kewaunee Scientific Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.